Literature DB >> 32553187

Seroconversion in household members of COVID-19 outpatients.

Rebecca J Cox1, Karl A Brokstad2, Florian Krammer3, Nina Langeland4.   

Abstract

Entities:  

Year:  2020        PMID: 32553187      PMCID: PMC7295487          DOI: 10.1016/S1473-3099(20)30466-7

Source DB:  PubMed          Journal:  Lancet Infect Dis        ISSN: 1473-3099            Impact factor:   25.071


× No keyword cloud information.
We read with interest the Article by Qifang Bi and colleagues, in which they reported a household secondary attack rate, as detected by repeated RT-PCR tests, of approximately 11%. We have found substantially higher attacks rates in western Norway through detection of antibodies to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). The first case of COVID-19 in Norway was identified in Bergen on Feb 28, 2020, before the outbreak was declared a pandemic, allowing rigorous testing of suspected cases before and during the rise in confirmed cases. All suspected COVID-19 cases in the peak period between Feb 28 and April 4 were referred to the Bergen municipality emergency room for centralised evaluation and testing according to a strict exposure likelihood algorithm, allowing an overview of the early virus spread in the population. If a family was exposed, only the index case was tested for SARS-CoV-2 infection. Both cases and household members were tested for specific antibodies to the receptor binding domain of SARS-CoV-2, as described by Stadlbauer and colleagues, at 6 weeks after the index patient tested positive by RT-PCR. Of 158 cases, 125 (79%) tested positive for antibodies and 12 (8%) were defined as borderline. In 77 household members, 24 (31%) tested positive and two (3%) were borderline. Our results show that detection of seroconversion might provide a more accurate picture of attack rates in households than intermittent RT-PCR testing.
  2 in total

1.  A serological assay to detect SARS-CoV-2 seroconversion in humans.

Authors:  Fatima Amanat; Daniel Stadlbauer; Shirin Strohmeier; Thi H O Nguyen; Veronika Chromikova; Meagan McMahon; Kaijun Jiang; Guha Asthagiri Arunkumar; Denise Jurczyszak; Jose Polanco; Maria Bermudez-Gonzalez; Giulio Kleiner; Teresa Aydillo; Lisa Miorin; Daniel S Fierer; Luz Amarilis Lugo; Erna Milunka Kojic; Jonathan Stoever; Sean T H Liu; Charlotte Cunningham-Rundles; Philip L Felgner; Thomas Moran; Adolfo García-Sastre; Daniel Caplivski; Allen C Cheng; Katherine Kedzierska; Olli Vapalahti; Jussi M Hepojoki; Viviana Simon; Florian Krammer
Journal:  Nat Med       Date:  2020-05-12       Impact factor: 53.440

2.  Epidemiology and transmission of COVID-19 in 391 cases and 1286 of their close contacts in Shenzhen, China: a retrospective cohort study.

Authors:  Qifang Bi; Yongsheng Wu; Shujiang Mei; Chenfei Ye; Xuan Zou; Zhen Zhang; Xiaojian Liu; Lan Wei; Shaun A Truelove; Tong Zhang; Wei Gao; Cong Cheng; Xiujuan Tang; Xiaoliang Wu; Yu Wu; Binbin Sun; Suli Huang; Yu Sun; Juncen Zhang; Ting Ma; Justin Lessler; Tiejian Feng
Journal:  Lancet Infect Dis       Date:  2020-04-27       Impact factor: 25.071

  2 in total
  3 in total

1.  Familial Clusters of Coronavirus Disease in 10 Prefectures, Japan, February-May 2020.

Authors:  Reiko Miyahara; Naho Tsuchiya; Ikkoh Yasuda; Yura K Ko; Yuki Furuse; Eiichiro Sando; Shohei Nagata; Tadatsugu Imamura; Mayuko Saito; Konosuke Morimoto; Takeaki Imamura; Yugo Shobugawa; Hiroshi Nishiura; Motoi Suzuki; Hitoshi Oshitani
Journal:  Emerg Infect Dis       Date:  2021-03       Impact factor: 16.126

2.  Durable T-cellular and humoral responses in SARS-CoV-2 hospitalized and community patients.

Authors:  Kristin G-I Mohn; Geir Bredholt; Fan Zhou; Anders Madsen; Therese B Onyango; Elisabeth B Fjelltveit; Sarah L Jalloh; Karl A Brokstad; Diego Cantoni; Martin Mayora-Neto; Nigel Temperton; Nina Langeland; Rebecca J Cox
Journal:  PLoS One       Date:  2022-02-22       Impact factor: 3.240

3.  Prevalence of SARS-CoV-2 in Household Members and Other Close Contacts of COVID-19 Cases: A Serologic Study in Canton of Vaud, Switzerland.

Authors:  Julien Dupraz; Audrey Butty; Olivier Duperrex; Sandrine Estoppey; Vincent Faivre; Julien Thabard; Claire Zuppinger; Gilbert Greub; Giuseppe Pantaleo; Jérôme Pasquier; Valentin Rousson; Malik Egger; Amélie Steiner-Dubuis; Sophie Vassaux; Eric Masserey; Murielle Bochud; Semira Gonseth Nusslé; Valérie D'Acremont
Journal:  Open Forum Infect Dis       Date:  2021-03-26       Impact factor: 3.835

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.